Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
Authors
Keywords
-
Journal
EJNMMI Research
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-12
DOI
10.1186/s13550-020-00652-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Accuracy of [68Ga]Ga-RM2-PET/CT for diagnosis of primary prostate cancer compared to histopathology
- (2019) Thomas F. Fassbender et al. NUCLEAR MEDICINE AND BIOLOGY
- 68Ga-PSMA-617 Compared With 68Ga-RM2 and 18F-FCholine PET/CT for the Initial Staging of High-Risk Prostate Cancer
- (2019) Romain Schollhammer et al. CLINICAL NUCLEAR MEDICINE
- Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity
- (2018) Marthe Løvf et al. EUROPEAN UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy
- (2016) Lars Budäus et al. EUROPEAN UROLOGY
- A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
- (2016) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results
- (2016) Berthold A. Nock et al. JOURNAL OF NUCLEAR MEDICINE
- Correlation of Intraprostatic Tumor Extent with 68Ga-PSMA Distribution in Patients with Prostate Cancer
- (2016) K. Rahbar et al. JOURNAL OF NUCLEAR MEDICINE
- Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist 68Ga-RM2 And PET
- (2016) Christian Stoykow et al. Theranostics
- 68Ga-HBED-CC-PSMA PET/CT Versus Histopathology In Primary Localized Prostate Cancer: A Voxel-Wise Comparison
- (2016) Constantinos Zamboglou et al. Theranostics
- The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
- (2015) Jonathan I. Epstein et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- 68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
- (2015) Francesco Ceci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Dosimetry and First Clinical Evaluation of the New 18F-Radiolabeled Bombesin Analogue BAY 864367 in Patients with Prostate Cancer
- (2015) B.-R. Sah et al. JOURNAL OF NUCLEAR MEDICINE
- Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
- (2015) M. Eiber et al. JOURNAL OF NUCLEAR MEDICINE
- Pilot Comparison of 68Ga-RM2 PET and 68Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer
- (2015) R. Minamimoto et al. JOURNAL OF NUCLEAR MEDICINE
- Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging
- (2015) Levent Kabasakal et al. NUCLEAR MEDICINE COMMUNICATIONS
- Nano-Enabled SERS Reporting Photosensitizers
- (2015) Arash Farhadi et al. Theranostics
- Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer
- (2014) Matthias Eder et al. PROSTATE
- In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548
- (2013) E. Kahkonen et al. CLINICAL CANCER RESEARCH
- Early over-expression of GRP receptors in prostatic carcinogenesis
- (2013) Meike Körner et al. PROSTATE
- Boosting imaging defined dominant prostatic tumors: A systematic review
- (2013) Glenn Bauman et al. RADIOTHERAPY AND ONCOLOGY
- Updated Results of Magnetic Resonance Imaging Guided Partial Prostate Brachytherapy for Favorable Risk Prostate Cancer: Implications for Focal Therapy
- (2012) Paul L. Nguyen et al. JOURNAL OF UROLOGY
- Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy
- (2011) Vladimir Mouraviev et al. BJU INTERNATIONAL
- Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial
- (2011) Irene M Lips et al. Trials
- The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer
- (2010) Simon R.J. Bott et al. BJU INTERNATIONAL
- Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
- (2010) Rosalba Mansi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeutic Radionuclides
- (2009) R. Mansi et al. CLINICAL CANCER RESEARCH
- Photodynamic therapy for prostate cancer—a review of current status and future promise
- (2009) Caroline M Moore et al. Nature clinical practice. Urology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now